What sector is PTNT in?

Healthcare, in the Pharmaceuticals industry.

Cboe BZX · PTNTHealthcarePharmaceuticals

Corgi IP Licensing & Royalties ETF (PTNT)

$24.11−1.84%

Close Sep 28, 2026 · split-adjusted

Sep 28, 2026$24.11▼ 1.41% in range

Sep 11, 2026Low $23.83 · High $24.72Sep 28, 2026

What changed · written from our data

As of Sep 28, 2026

Corgi IP Licensing & Royalties ETF closed at $24.11 on Sep 28, down 1.84%, within 1.2% of its lowest close since Sep 11. Volume of 97 shares was 1.27× its 20-day average (above normal).

Short interest was 147 shares at the Sep 15 settlement, down 57.6% from the prior report (2.8 days to cover).

Market cap—

Revenue · quarter——

Diluted EPS——

P/E · TTM—

Net margin—

Dividend yieldNone

Range since Sep 1123.83 – 24.72−2.5% from high

Volume971.27× 20-day avg

Volatility · 60d—Annualised

Short % of float—2.8 days to cover

Net cash—

Next earnings—Not scheduled

Split-adjusted performance

1W −1.9%1M —3M —6M —YTD —1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 423 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −2.9%, revenue growth +6.4%, net margin −41.2%, P/E 16.2×.

Short interest

Details →

Shares short147−57.6% vs prior

Days to cover2.8Settled Sep 15

% of float—

Short vol. 10d60.0%of daily volume

News about Corgi IP Licensing & Royalties ETF

All news →

No recent articles focused on Corgi IP Licensing & Royalties ETF.

Quick answers

What sector is PTNT in?: Healthcare, in the Pharmaceuticals industry.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology